INTRODUCTION
Portal hypertension is a common clinical syndrome, characterised by a sustained increase in portal venous pressure. It is defined as a wedged hepatic vein pressure or direct portal vein pressure of more than 5 mmHg greater than the inferior vena cava pressure, a splenic vein pressure of greater than 15 mm Hg or surgically measured portal venous pressure of greater than 30 cm water [1] . Portal hypertension syndrome is a common evolutive complication of several hepatic and extrahepatic diseases, liver cirrhosis responsible for more than 80% of cases. [2] When diagnosed it has prognostic value because of the high incidence of hemorrhagic, metabolic and infectious complications that these patients may develop, so clinical suspicion must be confirmed by objective complementary studies that provide information about the etiology and severity of the disease there by helps in timely implementation of surgical or medical management and thus prevent complication. However, actual direct measurements of portal pressures are obtained in only a small minority of patients. Consequently, non-invasive imaging modalities and in particular ultrasound, play a crucial role in the diagnosis and management of portal hypertension.
AIMS AND OBJECTIVES
 To evaluate the spectrum of duplex Ultrasonography findings in portal hypertension.  To assess the value of duplex Ultrasonography in the diagnosis of portal hypertension.
MATERIALS AND METHODS

Source of data:
This study is a hospital based study at Veer Surendra Sai Institute of Medical Sciences and Research (VIMSAR), Burla, Sambalpur, Odisha. Type of study: Cross sectional study. Sample: 100 patients were selected for our study randomly from the patients referred to the department of radiodiagnosis with the clinical suspicion / clinical diagnosis of portal hypertension, in the period of 2 years i.e. from December 2014 to November 2016. Inclusion criteria: All cases with clinical suspicion of portal hypertension. 
RESULTS
Total 100 patients were evaluated, most common etiology [ Fig-1 ] was found to be cirrhosis [ Fig-2 ] from various causes seen in 71 cases (71%). Portal vein occlusion was seen in 17 cases not having cirrhosis of liver, out of which 7 cases were due to malignancy.
Figure 1-Etiology of portal hypertension
No etiology could be determined by ultrasound in only 6% cases, one of which was found to be a case of segmental agenesis of segment 5 & 8 of liver, associated with portal hypertension [Fig-10 ]. Males were affected more than females, 72% males as against 28% females , with a male to female ratio of 2.6:1 and 59 % of cases were in the age group of 40-59 years. Portal vein diameter of >13 mm was noted in 58 out of 95 portal hypertension patients (61%) [Fig-4 [3, 4] .
The most common sinusoidal cause of obstruction to the portal blood flow is cirrhosis, which represents the final common result of a variety of insults to the liver. All types of cirrhosis lead to portal hypertension by causing obstruction to the portal flow. Portal flow is diverted into collaterals and some is directly shunted into hepatic venous radicles in the fibrous septa of the sinusoids.
Regardless of the etiology of cirrhosis, the end point of this pathologic process is fibrosis with architectural distortion and formation of regenerative nodules. The induction of fibrosis occurs with activation of hepatic stellate cells, resulting in the formation of increased amounts of collagen and other components of the extracellular matrix. This results in a loss of normal hepatocytes and thus function resulting in alteration of blood flow. Post -hepatic causes include Inferior vena cava obstruction, hepatic vein obstruction and cardiac diseases. In our study, we were able to ascertain the etiological cause of portal hypertension in 94% of our patients, Cirrhosis is being the most common cause (71%) for portal hypertension in our study (eastern Indian) population. Majority of the patients were middle aged males possibly due to higher consumption of alcohol leading to cirrhosis and portal hypertension.
On color Doppler normal portal vein exhibits a monophasic, low-velocity flow, with slight respiratory variation [5, 6] . In normal individuals the portal vein diameter can vary from < 13 mm in quiet respiration to 16 mm in deep inspiration, as measured where the portal vein crossed anteriorly to the inferior vena cava. Bolondi [7] , Zoli [8] and Kurol [9] all found in their respective studies that an enlarged portal vein was present in cases of portal hypertension. In 1984, La fortune found in his study that dilated portal vein was not diagnostic of portal hypertension [10] . He correlated his findings with angiography to confirm his data. Bradley Koslin in his study also found that diameter alone was not diagnostic of portal hypertension [11] . Enlarged portal vein diameter has high specificity but low sensitivity for diagnosis of portal hypertension. While it is true that an unusually large portal vein is a reliable sign of portal hypertension, it is also unfortunately true that a normal-sized portal vein in no way excludes the diagnosis [12] . Extensive review of literature conducted by Van Leeven also confirmed that diameter of portal vein was not a diagnostic criteria for portal hypertension [13] . In our study dilated portal vein was noted in 61% of cases.
In normal individuals the calibre of the portal vein changes from 20-200% between phases of respiration. Zoli in his study found that the respiratory variation in the portal vein calibre is reduced in portal hypertension [8] .The average variation between inspiration and expiration was less than 20% in portal hypertensives, and the sensitivity of this sign in diagnosing portal hypertension was 82% [14] . Similar results were seen in our study. Loss of respiratory phasicity of portal vein was noted in 84% cases. Possible explanation is, as elevated portal pressure maximizes venous distension, so little or no additional distension will occur when the portal vein outflow is indirectly restricted by sustained inspiration. [12] The velocity in the portal vein is approximately 15-18 cm/sec with a lot of variation in the range. The velocity decreases in cases where there is increased resistance to the portal blood flow as postulated by Patriquin and Bradley Koslin [15, 11] . However in our study no significant association with reduced mean velocity was noted, only 44 % cases showed decreased value. The mean PV velocity may vary depending on the presence and location of spontaneous shunts. The velocity tends to increase in the presence of a patent paraumbilical vein and decrease in the presence of splenorenal collaterals. La Fortune and found that hepatofugal flow is an absolute sign of portal hypertension with a sensitivity of 85% and specificity of 100% [10] . In our study only 4 had hepatofugal flow which is similar to study by Takayaso's, where 2 cases had hepatofugal flow among 80. According to him, reversal of flow in the portal vein is rare in the absence of surgical shunts [16] Alexandra Von et al.,
found direction of portal vein flow was normal in 73%, hepatofugal in 9% and bidirectional in 6% patients [17] , similar to our study. Hepatofugal flow not a common finding but its presence is an absolute sign of portal hypertension and very well correlates with severity of disease.
Knowing that portal vein cross-sectional area typically increases and portal velocity typically decreases in the setting of portal hypertension has led some investigators to study the ratio of these parameters, assuming that it will increase dramatically with portal hypertension. Congestion index was introduced by Moriyasu et al (1986) [18] to address counter current changes of sectional area and blood flow in portal hypertension. They showed that the congestion index was 2.5 times higher in patients with cirrhosis and portal hypertension than in normal subjects. Haag K et al (1999) [19] concluded that the "congestion index" above 0.1 suggests the diagnosis of portal hypertension with a 95% sensitivity and specificity. In our study 92.5 % patients showed congestion index ≥0.1 and only 7.5% had CI of <0.1 suggesting significant association between portal hypertension and CI . Portal vein occlusion is principally caused by thrombosis (bland thrombus), tumour invasion and compression. Thrombosis may be precipitated by stagnant portal flow in patients with cirrhosis or can be a cause of portal hypertension. Other causes include hypercoagulable states, surgery, and intraperitoneal inflammatory processes, such as pancreatitis and appendicitis. In our study, 18 cases of portal vein thrombosis was found, of which 10 cases had complete thrombosis & 8 had partial thrombosis. In our study splenomegaly was noted in 93% of cases. La Fortune in his series found splenomegaly in 80% cases [10] . is a non-specific finding but is frequently seen in portal hypertension. In our study 85% cases shows ascites, majority having moderate ascites. Detection of abnormal collateral vessels appears to be one of the most sensitive (70-83%) and specific sonographic signs for the diagnosis of portal hypertension.
[20]
In our study, portosystemic collaterals were visualised in 92 % of the cases. Most frequent collaterals visualised were the splenorenal collaterals which were seen in 87 % of cases. GE junction collaterals and paraumbilical veins were seen in 56 and 42 % of cases respectively. The increased frequency of Splenorenal may be due to their easier detection because of their location and small GEJ collaterals which were not detected by ultrasonography. Thus, most of the findings in the study were found to correlate with the previous studies related to portal hypertension.
LIMITATIONS
There are still drawbacks in assessment of portal hypertension using ultrasonography, like lack of standard scoring system for intercommunication between observers, inter observer variability, inter machine variability, interference caused by obesity, bowel gas, different states of fasting, and limitation of abdominal ultrasound to assess collaterals like haemorrhoids, retroperitoneal collaterals and esophageal varices. Another limitation of the present study was that diagnosis of portal hypertension was based on the combination of clinical, endoscopic and US findings. Objective measurements were not done to prove the diagnosis.
CONCLUSION
Portal hypertension is a commonly encountered clinical condition with multiple causes and several sequelae. The various spectrums of findings of portal hypertension, flow metric changes and portosystemic collaterals can be accurately studied using duplex ultrasonography. Though Portal vein diameter and velocity alone were nonsignificant, loss of respiratory phasicity, congestion index, portosystemic collaterals and presence of splenomegaly and ascites shows significant association with portal hypertension. Hepatofugal flow and presence of portosystemic collaterals are diagnostic of portal hypertension. Most importantly Ultrasonography is a reliable investigation for assessing etiology of portal hypertension as we can diagnose causes like cirrhosis, portal vein occlusion or Budd-Chiari syndrome accurately by ultrasound.
